|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.58/0.04
|
企業價值
109.20M
|
資產負債 |
每股賬面淨值
-0.54
|
現金流量 |
現金流量率
--
|
損益表 |
收益
81.76M
|
每股收益
1.73
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/06/14 21:08 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States. |